Early experience using calcineurin-free protocol in recipients of high-risk cadaver renal transplants

Transplant Proc. 2002 Aug;34(5):1627-8. doi: 10.1016/s0041-1345(02)02957-3.

Authors

R El-Sabrout¹, V Delaney, F Butt, M Qadir, I Rashid, P Hanson, K Butt

Affiliation

¹ Departments of Transplantation/Vascular Surgery, New York Medical College, Valhalla, New York, USA.

PMID: 12176512
DOI: 10.1016/s0041-1345(02)02957-3

No abstract available

MeSH terms

Cadaver
Calcineurin*
Follow-Up Studies
Graft Survival / drug effects
Graft Survival / physiology*
Humans
Immunosuppressive Agents / therapeutic use*
Kidney Transplantation / immunology
Kidney Transplantation / physiology*
Mycophenolic Acid / analogs & derivatives
Mycophenolic Acid / therapeutic use*
New York
Racial Groups
Risk Assessment
Sirolimus / therapeutic use*
Time Factors
Tissue Donors

Substances

Immunosuppressive Agents
Calcineurin
Mycophenolic Acid
Sirolimus